reports
Kitron ASA: New share capital registered
Kitron ASA: New share capital registered (2026-01-13) Reference is made to the stock exchange announcements made by Kitron ASA (the "Company" or "Kitron") on 19 November 2025 regarding the entering into agreement to, through its subsidiary Kitron Holding AB, acquire DeltaNordic AB (the "Transaction"), and on 12 January 2026 regarding completion of the Transaction and issuance of consideration shares. The share capital increase pertaining to the consideration shares has now been registered in the Norwegian Register of Business Enterprises today. The Company's new registered share capital fo...
Kitron ASA: Ny aksjekapital registrert
Kitron ASA: Ny aksjekapital registrert (2026-01-13) Det vises til børsmeldinger fra Kitron ASA ("Selskapet" eller "Kitron") den 19. november 2025 om inngåelse av avtale om, gjennom datterselskapet Kitron Holding AB, å kjøpe DeltaNordic AB ("Transaksjonen") og den 12. januar 2026 om gjennomføring av Transaksjonen og utstedelse av vederlagsaksjer. Kapitalforhøyelsen i forbindelse med vederlagsaksjene har i dag blitt registrert i Foretaksregisteret. Selskapets nye registrerte aksjekapital etter registreringen er NOK 21 870 247,10 fordelt på 218 702 471 aksjer, hver pålydende NOK 0,10. Hver ak...
- Emmanuel Matot
Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant t...
Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant to Research Collaboration with Centessa Tokyo, Japan and Cambridge, UK, 13 January 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Centessa Pharmaceuticals has achieved an early development milestone associated with its investigational, orally administered, highly potent and selective orexin receptor 2 (OX2R) agonist, ORX142, in development for the treatment of neurological and neurodegenerative disorders. This milestone triggers a payment of US$3.6 million to Nxera pursuant to its research co...
- Mathijs Geerts Danau
Pharvaris Business update narrows topline prophylactic phase 3 data to...
Pharvaris provided a business update, which comes with narrowed guidance for the topline data from the phase 3 (CHAPTER-3) trial of deucrictibant in HAE prophylaxis, now expected in 3Q26 (previously 2H26). We're confident going into this readout, which we believe has a high probability of success based on the strong efficacy shown in phase 2. With the NDA filing in the on-demand setting on track for 1H26, and another phase 3 ongoing in AAE-C1INH, the product is set to address the broadest group ...
- ABGSC Credit Research
- Andreas Johannessen
- Bendik Fougner Engebretsen
- Glenn Kringhaug
- Håkon Aakre
- Patrik Brattelius
- Sharish Aziz
- Stian Wibstad
Kandi Technologies Showcases at AIMExpo 2026, Deepening North American...
Kandi Technologies Showcases at AIMExpo 2026, Deepening North American Channel Strategy and Business Expansion Jinhua, China , Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (“Kandi”, “Kandi Technologies”, or the “Company”) (NASDAQ GS: KNDI), a long renowned leader in all-electric personal transportation and utility vehicles, today announced its participation in American International Motorcycle Expo (“AIMExpo”) for the year 2026, held from January 7 to 9, 2026 at the Anaheim Convention Center in California. During the event, Kandi showcased its core lineup of electric...
- Jacob Mekhael
- Livio Luyten
- Mathijs Geerts Danau
- Wim Hoste
Inter & Co Inc: 1 director
A director at Inter & Co Inc sold 374,688 shares at 45.711BRL and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
- Pierre Tegner
GFH Financial Group B.S.C: 1 director
A director at GFH Financial Group B.S.C bought 649,400 shares at 0.585USD and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
National Bank Of Greece: 1 director
A director at National Bank Of Greece sold after exercising options/sold 3,500 shares at 14.243EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dire...
Unitronics (1989) (R''''G) Ltd: 1 director
A director at Unitronics (1989) (R''G) Ltd bought 95,000 shares at 26.000ILS and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
Moody's Ratings assigns provisional ratings to colocation data center ...
Moody's Ratings (Moody's) has assigned provisional ratings to DataBank Holdings, Ltd.'s (DataBank) Secured Data Center Revenue Term Notes, Series 2026-1, Class A-2 Notes (the class A-2 term notes), and the Secured Data Center Revenue Term Notes, Series 2026-1 Class B Notes (the class B term notes, a...
- Chris Turner
- Francesco Pesole
- Frantisek Taborsky
FX Daily: CPI can help USD recover as Fed fears ease
The pushback from some Republican lawmakers against the DoJ probe on Fed Chair Powell has eased market nerves. And while more reassurances are likely needed, that may be enough for today, allowing the dollar to continue recovering, as we expect the US December core CPI to come in above consensus at 0.4% MoM. EUR/USD may touch 1.1600 soon
- Research Team
WOOD Daily: ESLT US; ZAB PW; DVL PW; HUG PW; CEZ CP; MTLN GA
HEADLINES: • Elbit Systems: bags new DIRCM contract from APAC POSITIVE • Zabka: 4Q25 trading update – sales +14.4% on lfl of 4.8%; FY adjusted EBITDA margin maintained at upper end of 12-13% range NEUTRAL • Develia: sells 3.3k units in 2025, at the top of the guided range NEUTRAL • Huuuge Games: preliminary 4Q25 revenue at USD 58.6m, down 5% yoy, but up 5% qoq POSITIVE • CEZ: informs customers about the cancelling of the RES surcharge NEUTRAL • Metlen Energy & Metals: expands local Defence Hub f...
Sidetrade Advances Security Leadership with SOC 1® Type II, SOC 2® Typ...
Sidetrade Advances Security Leadership with SOC 1® Type II, SOC 2® Type II Reports and ISO 27001 Certification as AI Footprint Expands , the Order-to-Cash AI company, announced it has obtained SOC 1® Type II and SOC 2® Type II reports with an unmodified auditor’s opinion, following audits conducted by EY France, and completed a full ISO/IEC 27001:2022 recertification. The results validate the company’s control maturity, data protection practices, and operational resilience at scale, as enterprises increasingly demand verifiable assurances on AI governance and financial process integrity, pa...
Sidetrade renforce son dispositif de confiance avec l’obtention des ra...
Sidetrade renforce son dispositif de confiance avec l’obtention des rapports SOC 1® Type II et SOC 2® Type II et le renouvellement de sa certification ISO 27001 , leader mondial des applications d’IA dédiées à l’Order-to-Cash, annonce l’obtention des rapports d’assurance SOC 1® Type II et SOC 2® Type II, à l’issue d’audits réalisés par EY France, ainsi que la certification ISO/IEC 27001:2022. Ces résultats valident la maturité des dispositifs de contrôle du Groupe, ses pratiques de protection des données et sa résilience opérationnelle à grande échelle, alors que les entreprises exigent de ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.